Target Price | $238.65 |
Price | $233.06 |
Potential | 2.40% |
Number of Estimates | 40 |
40 Analysts have issued a price target Zscaler, Inc. 2026 . The average Zscaler, Inc. target price is $238.65. This is 2.40% higher than the current stock price. The highest price target is $270.00 15.85% , the lowest is $195.00 16.33% . | |
A rating was issued by 47 analysts: 33 Analysts recommend Zscaler, Inc. to buy, 14 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Zscaler, Inc. stock has an average upside potential 2026 of 2.40% . Most analysts recommend the Zscaler, Inc. stock at Purchase. |
40 Analysts have issued a sales forecast Zscaler, Inc. 2025 . The average Zscaler, Inc. sales estimate is $2.6b . This is 9.41% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.7b 10.04% , the lowest is $2.6b 9.17% .
This results in the following potential growth metrics:
2024 | $2.2b | 34.07% |
---|---|---|
2025 | $2.6b | 22.24% |
2026 | $3.2b | 20.20% |
2027 | $3.8b | 20.16% |
2028 | $4.5b | 16.64% |
2029 | $5.3b | 17.92% |
12 Analysts have issued an Zscaler, Inc. EBITDA forecast 2025. The average Zscaler, Inc. EBITDA estimate is $666m . This is 74,730.28% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $695m 77,937.97% , the lowest is $650m 72,908.37% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $-43.0m | 63.11% |
---|---|---|
2025 | $666m | 1,650.62% |
2026 | $840m | 26.17% |
2027 | $1.0b | 24.76% |
2024 | -1.98% | 72.48% |
---|---|---|
2025 | 25.13% | 1,368.36% |
2026 | 26.38% | 4.97% |
2027 | 27.39% | 3.83% |
17 Zscaler, Inc. Analysts have issued a net profit forecast 2025. The average Zscaler, Inc. net profit estimate is $-60.2m . This is 289.19% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $9.3m 159.98% , the lowest is $-130m 737.52% .
This results in the following potential growth metrics and future Net Margins:
2024 | $-60.3m | 72.14% |
---|---|---|
2025 | $-60.2m | 0.21% |
2026 | $-20.8m | 65.46% |
2027 | $29.5m | 241.63% |
2024 | -2.78% | 79.22% |
---|---|---|
2025 | -2.27% | 18.45% |
2026 | -0.65% | 71.37% |
2027 | 0.77% | 218.46% |
17 Analysts have issued a Zscaler, Inc. forecast for earnings per share. The average Zscaler, Inc. EPS is $-0.39 . This is 290.00% lower than earnings per share in the financial year 2024. The highest EPS forecast is $0.06 160.00% , the lowest is $-0.84 740.00% .
This results in the following potential growth metrics and future valuations:
2024 | $-0.39 | 72.14% |
---|---|---|
2025 | $-0.39 | 0.00% |
2026 | $-0.13 | 66.67% |
2027 | $0.19 | 246.15% |
Current | -2,256.15 | 1,102.77% |
---|---|---|
2025 | -598.84 | 73.46% |
2026 | -1,733.74 | 189.52% |
2027 | 1,224.24 | 170.61% |
Based on analysts' sales estimates for 2025, the Zscaler, Inc. stock is valued at an EV/Sales of 12.99 and an P/S ratio of 13.61 .
This results in the following potential growth metrics and future valuations:
Current | 14.21 | 6.36% |
---|---|---|
2025 | 12.99 | 8.59% |
2026 | 10.81 | 16.80% |
2027 | 8.99 | 16.78% |
2028 | 7.71 | 14.26% |
2029 | 6.54 | 15.20% |
Current | 14.89 | 6.33% |
---|---|---|
2025 | 13.61 | 8.60% |
2026 | 11.32 | 16.80% |
2027 | 9.42 | 16.78% |
2028 | 8.08 | 14.26% |
2029 | 6.85 | 15.20% |
Analyst | Rating | Action | Date |
---|---|---|---|
Roth Capital |
➜
Neutral
|
Initiated | Apr 23 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 16 2025 |
Rosenblatt |
Buy
➜
Buy
|
Unchanged | Apr 15 2025 |
Cantor Fitzgerald |
Neutral
➜
Overweight
|
Upgrade | Apr 03 2025 |
Stephens & Co. |
➜
Overweight
|
Initiated | Apr 01 2025 |
Jefferies |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
B of A Securities |
Neutral
➜
Buy
|
Upgrade | Mar 07 2025 |
Analyst Rating | Date |
---|---|
Initiated
Roth Capital:
➜
Neutral
|
Apr 23 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Apr 16 2025 |
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Apr 15 2025 |
Upgrade
Cantor Fitzgerald:
Neutral
➜
Overweight
|
Apr 03 2025 |
Initiated
Stephens & Co.:
➜
Overweight
|
Apr 01 2025 |
Unchanged
Jefferies:
Buy
➜
Buy
|
Mar 31 2025 |
Upgrade
B of A Securities:
Neutral
➜
Buy
|
Mar 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.